LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $16,726,000 | +8.4% | 2,245,199 | +1.2% | 0.00% | 0.0% |
| Q4 2016 | $15,423,000 | -12.6% | 2,219,160 | +3.4% | 0.00% | 0.0% |
| Q3 2016 | $17,656,000 | +34.4% | 2,145,359 | +32.3% | 0.00% | 0.0% |
| Q2 2016 | $13,136,000 | +59.1% | 1,621,810 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $8,259,000 | -29.2% | 1,625,946 | +7.6% | 0.00% | 0.0% |
| Q4 2015 | $11,661,000 | +41.5% | 1,510,556 | +5.6% | 0.00% | – |
| Q3 2015 | $8,242,000 | -29.2% | 1,430,956 | +12.7% | 0.00% | -100.0% |
| Q2 2015 | $11,639,000 | +251.1% | 1,269,233 | +363.6% | 0.00% | – |
| Q1 2015 | $3,315,000 | – | 273,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |